cyc 202 has been researched along with Brain Ischemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Amara, A; Le Roux, C; Le Roy, L; Letondor, A; Timsit, S | 1 |
| Courbebaisse, Y; Létondor, A; Menn, B; Quillé, ML; Rousselet, E; Timsit, S | 1 |
| Gao, C; Gao, L; Luo, X; Yan, J; Zhao, C; Zhao, J; Zhao, W; Zhu, X | 1 |
| Di, Q; Xu, L; Zhang, Y | 1 |
| Chen, C; Dong, Q; Lü, J; Luo, X; Pan, D; Wang, W; Xie, M; Yu, Z; Zhang, Q | 1 |
| Bach, S; Blevins, TL; Campbell, M; Meijer, L; Menn, B; Timsit, S | 1 |
| Menn, B; Timsit, S | 1 |
| Brun-Zinkernagel, AM; Koulen, P; Liu, R; Simpkins, JW; Wen, Y; Yang, S | 1 |
| Schmid, G; Strosznajder, JB; Wesierska-Gadek, J | 1 |
2 review(s) available for cyc 202 and Brain Ischemia
| Article | Year |
|---|---|
Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells.
Topics: Animals; Brain; Brain Ischemia; Cyclin-Dependent Kinases; Humans; Leukocytes; Models, Biological; Roscovitine | 2021 |
Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Cycle; Cyclin-Dependent Kinase 5; Humans; Kinetin; Neurodegenerative Diseases; Neurons; Protein Kinase Inhibitors; Purines; Roscovitine; Tumor Suppressor Protein p53 | 2006 |
7 other study(ies) available for cyc 202 and Brain Ischemia
| Article | Year |
|---|---|
Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study.
Topics: Animals; Brain Edema; Brain Ischemia; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Roscovitine | 2018 |
Cdk5 is required for the neuroprotective effect of transforming growth factor-β1 against cerebral ischemia-reperfusion.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Brain Ischemia; Cell Differentiation; Cell Proliferation; Cyclin-Dependent Kinase 5; Indazoles; MAP Kinase Signaling System; Neurites; Neuroprotective Agents; PC12 Cells; Piperazines; Protein Kinase Inhibitors; Purines; Rats; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Roscovitine; Transforming Growth Factor beta1 | 2017 |
Cell cycle proteins preceded neuronal death after chronic cerebral hypoperfusion in rats.
Topics: Animals; Apoptosis; Blotting, Western; Brain; Brain Damage, Chronic; Brain Ischemia; Carotid Artery, Common; Cell Cycle Proteins; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 4; Disease Models, Animal; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraventricular; Ligation; Male; Maze Learning; Memory; Neurons; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Spatial Behavior; Time Factors | 2008 |
Cell cycle inhibition attenuates microglial proliferation and production of IL-1beta, MIP-1alpha, and NO after focal cerebral ischemia in the rat.
Topics: Animals; Aquaporins; Brain Ischemia; Cell Count; Cell Cycle; Cell Line, Transformed; Cell Proliferation; Disease Models, Animal; Eye Proteins; In Situ Nick-End Labeling; Injections, Intraventricular; Interleukin-1beta; Male; Mice; Microglia; Neurologic Examination; Nitric Oxide; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Tetrazolium Salts; Up-Regulation | 2009 |
Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models.
Topics: Animals; Brain Ischemia; Cell Death; Chemistry, Pharmaceutical; Cyclin-Dependent Kinase 5; Disease Models, Animal; Drug Administration Routes; Humans; Injections; Male; Mice; Mitosis; Neuroprotective Agents; Purines; Rats; Roscovitine; Stroke; Time Factors | 2010 |
Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Cyclin-Dependent Kinases; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Models, Biological; Neuroprotective Agents; Protein Kinase Inhibitors; Purines; Roscovitine; Stroke | 2012 |
Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats.
Topics: Alzheimer Disease; Animals; Antigens; Apoptosis; Brain Ischemia; Cell Cycle; Cell Death; Cerebral Cortex; Enzyme Inhibitors; Epitopes; Estradiol; Female; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Ischemia; Microscopy, Electron; Microscopy, Fluorescence; Mitosis; Neurons; Phosphorylation; Protein Conformation; Protein Kinases; Purines; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Roscovitine; Tauopathies; Time Factors | 2004 |